RevBio, Inc., announced that it has been awarded a $2.2 million Phase II Small Business Innovation Research (SBIR) grant from the National Institute on Aging (NIA), part of the National Institutes of Health (NIH).
This Grant will Advance the Company’s Preclinical Research to Demonstrate an Improvement to the Current Standard of Care for Treating Vertebral Compression Fractures
This Grant will Advance the Company’s Preclinical Research to Demonstrate an Improvement to the Current Standard of Care for Treating Vertebral Compression Fractures
Across the United States, healthcare systems are investing billions of dollars in new hospitals, specialty centers, and campus redevelopments that will shape the future of patient care for decades to come.
For the hundreds of thousands of Americans who undergo heart bypass surgery each year, the relief of surviving such a major procedure is often shadowed by one sobering fact: The risk of another heart attack or stroke still lingers.
For the hundreds of thousands of Americans who undergo heart bypass surgery each year, the relief of surviving such a major procedure is often shadowed by one sobering fact: The risk of another heart attack or stroke still lingers.
For the hundreds of thousands of Americans who undergo heart bypass surgery each year, the relief of surviving such a major procedure is often shadowed by one sobering fact: The risk of another heart attack or stroke still lingers.
For the hundreds of thousands of Americans who undergo heart bypass surgery each year, the relief of surviving such a major procedure is often shadowed by one sobering fact: The risk of another heart attack or stroke still lingers.
